Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension.

@article{Chen2009BloodPL,
  title={Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension.},
  author={Jenny Mh Chen and Balraj S. Heran and James M. Wright},
  journal={The Cochrane database of systematic reviews},
  year={2009},
  volume={4},
  pages={
          CD007187
        }
}
BACKGROUND Diuretics are widely prescribed for hypertension not only as a first-line drug but also as a second-line drug. Therefore, it is essential to determine the effects of diuretics on blood pressure (BP), heart rate and withdrawals due to adverse effects (WDAEs) when given as a second-line drug. OBJECTIVES To quantify the additional reduction in systolic blood pressure (SBP) and diastolic blood pressure (DBP) of diuretic therapy as a second-line drug in patients with primary… 
View on PubMed
doi.org
33 Citations
Highly Influential Citations
2
Background Citations
7

33 Citations

Citation Type

Citation Type

Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.
TLDR
Second-line beta-blockers reduce systolic blood pressure to the same extent as second-line thiazide diuretics, but reduce diastolic BP to a greater degree, whereas thiazides cause a significant dose-related decrease in pulse pressure.
Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension.
TLDR
ENaC blockers do not have a statistically or clinically significant BP lowering effect at low doses but trials at higher doses are not available, and the review did not provide a good estimate of the incidence of harms associated with ENaC blocker.
Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension.
TLDR
ENaC blockers do not have a statistically or clinically significant BP lowering effect at low doses but trials at higher doses are not available, and the review did not provide a good estimate of the incidence of harms associated with ENaC blocker.
Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
TLDR
The dose-related decrease in systolic and/or diastolic blood pressure due to thiazide diuretics compared with placebo control in the treatment of patients with primary hypertension was determined.
Blood pressure-lowering efficacy of loop diuretics for primary hypertension.
TLDR
The quality of evidence was graded as "low" due to the high risk of bias of included studies and the high likelihood of publication bias, and no clinically meaningful blood pressure-lowering differences between different drugs within the loop diuretic class were found.
[Antihypertensive drugs in 2010: old and new agents].
  • M. Leeman
  • Medicine, Biology
    Revue medicale de Bruxelles
  • 2010
TLDR
There is no evidence that "new" antihypertensive agents are superior to "old" agents, and the results of ongoing long-term outcome studies will determine the place of aliskiren in the treatment of hypertension.
The evidence-based use of thiazide diuretics in hypertension and nephrolithiasis.
TLDR
The authors believe chlorthalidone is a safe option in hypertensive patients who have had a stroke and when adding a thiazide to other drug classes, and HCTZ has a safe track record in several patient groups.
Aliskiren-Hydrochlorothiazide in Combination: Efficacy Review in Mild to Moderate Hypertension
TLDR
The efficacy and safety of aliskiren alone and in the combination with hydrochlorothiazide, an interesting combination partner since their mode of action allows synergistic effects in regard to lowering blood pressure as well as in reducing possible side effects of both drugs.
Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics
TLDR
The clinical pharmacology of thiazide diuretics is reviewed to provide an insight into the mechanisms involved in their antihypertensive and adverse effects, the determinants of drug response and the possible differences in their pharmacodynamic and pharmacokinetic properties in an attempt to improve their clinical use in the treatment of arterial hypertension.
Augmented antihypertensive effect of a fixed combination formula of candesartan and hydrochlorothiazide combined with furosemide in a patient on peritoneal dialysis
TLDR
This case suggests that when used in combination, diuretics acting on different functional segment of the nephron hold greater potential for enhanced antihypertensive effect, especially in patients on PD whose residual renal function is well preserved.
...
1
2
3
4
...

References

SHOWING 1-10 OF 149 REFERENCES
Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.
TLDR
Second-line beta-blockers reduce systolic blood pressure to the same extent as second-line thiazide diuretics, but reduce diastolic BP to a greater degree, whereas thiazides cause a significant dose-related decrease in pulse pressure.
A systematic review of the blood pressure lowering efficacy of thiazide and loop diuretics in the treatment of primary hypertension
TLDR
The lowest range of clinically used doses of thiazide diuretic showed near maximal blood pressure lowering efficacy and a lower incidence of adverse metabolic effects and it is recommended that there is no advantage to using doses higher than those defined as low dose.
Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
TLDR
There are no clinically meaningful BP lowering differences between different ACE inhibitors and the review did not provide a good estimate of the incidence of harms associated with ACE inhibitors because of the short duration of the trials and the lack of reporting of adverse effects in many of the Trials.
Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension.
TLDR
The BP lowering effect of ARBs is modest and similar to ACE inhibitors as a class; the magnitude of average trough BP lowering for ARBs at maximum recommended doses and above is -8/-5 mmHg.
First-line drugs for hypertension.
TLDR
First-line low-dose thiazides reduce all morbidity and mortality outcomes and first-line ACE inhibitors and calcium channel blockers are inferior to first-liners beta-blockers.
Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?
TLDR
Low-dose thiazide therapy can be prescribed as the first-line treatment of hypertension with confidence that the risk of death, coronary artery disease and stroke will be reduced, and was significantly better at reducing systolic blood pressure than the other drug classes.
Influence of an angiotensin converting-enzyme inhibitor on diuretic-induced metabolic effects in hypertension.
TLDR
Two multicenter trials compared the effects of captopril combined with a diuretic to the administration of either agent alone in mild-to-moderate hypertensives, and blood pressure and effects on serum potassium, uric acid, glucose, and cholesterol were examined.
Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial.
TLDR
The results suggest that moderate salt restriction used as sole treatment has a limited though demonstrable blood pressure lowering effect but that when it is used as an adjuvant to beta blocker treatment its value is greatly enhanced.
Once-daily treatment of essential hypertension with captopril.
TLDR
Captopril given once daily, alone or in combination with hydrochlorothiazide, is efficacious treatment for patients with mild-to-moderate hypertension and the once-daily regimen should further enhance patient compliance.
...
1
2
3
4
5
...